Researchers study children at risk for Tourette syndrome
Neuroscientists at Washington University School of Medicine in St. Louis are studying children who may be at risk for Tourette Syndrome due to the onset of motor and/or vocal tics. Many kids develop tics that later disappear, but the researchers want to learn why for some, those tics represent the beginnings of Tourette Syndrome.
Consistent exercise associated with lower risk of colon cancer death
Consistent exercise is associated with a lower risk of dying from colon cancer, according to a new study led by Siteman Cancer Center researchers. The study is among the first to show that physical activity can make the disease less deadly.
Risk for alcoholism linked to risk for obesity
Addiction researchers at Washington University School of Medicine in St. Louis have found that a risk for alcoholism also may put individuals at risk for obesity, and the association between a family history of alcoholism and obesity risk has become more pronounced in recent years.
MRI scans reveal brain changes in people at genetic risk for Alzheimer’s
People with a known, high risk for Alzheimer’s disease develop abnormal brain function even before the appearance of telltale, amyloid plaques that are characteristic of Alzheimer’s disease, according to a new study from researchers at Washington University School of Medicine in St. Louis. The findings suggest that a gene variant affects brain function long before the brain begins accumulating the amyloid that will eventually lead to dementia.
Spine center opens in Chesterfield
Washington University Orthopedics has opened a spine center at its outpatient facility in Chesterfield, Mo., to provide comprehensive, specialized care to patients with spine injuries and disorders.
Washington University opens clinic for treatment-resistant depression
Washington University School of Medicine has opened a clinic for patients with treatment-resistant depression that targets those who haven’t responded to standard therapies. When at least two therapies have been tried, and a patient still hasn’t responded, that patient is said to have treatment-resistant depression, according to clinic director Charles R. Conway, MD.
Brain scans show effects of Parkinson’s drug
Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson’s disease get into a patient’s brain and affect blood flow in several key structures, an indicator the drug may be effective. In the future, similar brain scans could speed the development of new drugs and help clinicians learn whether established drugs are working.
CT screening reduces lung-cancer deaths in heavy smokers
In a study of heavy smokers, fewer screened with low-dose CT scans died, compared with similar smokers screened with standard chest X-rays. The National Cancer Institute ran the 33-center National Lung Screening Trial to learn whether more sensitive screening could have an impact on lung-cancer deaths, and Washington University researchers involved in the study say it did.
Going where the science takes you
Evan Kharasch, MD, PhD, has been involved in scientific research since high school. An anesthesiologist by training, he is the Russell D. and Mary B. Shelden Professor of Anesthesiology and professor of biochemistry and molecular biophysics. Last spring, he also was appointed vice chancellor for research for the university.
Gene identified for spread of deadly melanoma
Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of melanoma of the eye. Although more research is needed, the researchers say the discovery is an important step in understanding why some tumors spread and others don’t, and they believe the findings could lead to more effective future treatments.
View More Stories